News Provided By
Share This Article
Artificial Intelligence In Oncology Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company's Artificial Intelligence In Oncology Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
It will grow to $5.63 billion in 2028 at a compound annual growth rate (CAGR) of 33.3%.”
— The Business Research Company
LANDON, GREATER LANDON, UK, June 25, 2024 / EINPresswire.com / -- The artificial intelligence (AI) in oncology market is projected to grow from $1.33 billion in 2023 to $1.78 billion in 2024, at a CAGR of 33.7%. This robust growth is driven by the rising incidence of cancer, data proliferation in healthcare, clinical trial optimization, and the demand for personalized medicine. By 2028, the market is anticipated to reach $5.63 billion, growing at a CAGR of 33.3%, fueled by advancements in electronic health records (EHR), treatment decision support, patient engagement, and regulatory support. Rising Incidence of Cancer Propels Market Growth
The increasing incidence of cancer significantly contributes to the growth of the AI in oncology market. Cancer's complexity, characterized by the uncontrolled growth and division of abnormal cells, demands precise, personalized, and efficient care, which AI integration facilitates. According to a 2023 report by the American Cancer Society Inc., new cancer cases increased from 1.8 million to 1.9 million, highlighting the growing need for innovative cancer care solutions driven by AI. Explore comprehensive insights into the global AI in oncology market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=13130&type=smp
Major Players
Major companies operating in the AI in oncology market include Azra AI, IBM Corporation, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI Inc., PathAI Inc., Median Technologies SA, Kheiron Medical Technologies Ltd., Hampton Research Inc., Tempus Labs Inc., Paige AI Inc., Prognos Health Inc., Enlitic, Inspirata Inc., Berg LLC, Proscia Inc., Deep 6 AI Inc., Ibex Medical Analytics, Nanox Imaging Ltd., Zebra Medical Vision, and Globavir Biosciences Inc.
Focus on Cloud-Based Software for Enhanced Efficacy
Companies in the AI in oncology market are focusing on developing innovative software, particularly cloud-based solutions, to enhance their efficacy. These platforms enable scalable, flexible, and accessible processing and analysis of large medical data volumes. For instance, in March 2023, Illumina Inc. launched Connected Insights, a cloud-based software that streamlines the interpretation and reporting of oncology results, expanding the use of Next-Generation Sequencing (NGS) and accelerating clinical reporting turnaround times. Segments:
1) By Component: Software Solutions, Hardware, Services
2) By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Other Treatment Types
3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Cancer Types
4) By Application: Cancer Detection, Drug Discovery, Drug Development, Other Applications
5) By End-Users: Hospitals, Diagnostic Centers, Pharmaceutical Companies, Research Institutes, Other End Users
Geographical Insights: North America Leading the Market
North America led the AI in oncology market in 2023 and is expected to maintain its leadership. However, Asia-Pacific is projected to be the fastest-growing region during the forecast period. The report covers various regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa, providing detailed insights into regional dynamics and growth opportunities. Access the complete report for an in-depth analysis of the global AI in oncology market:
Market size data for the forecast period: Historical and Future
Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa. Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. Trends, opportunities, strategies and so much more. The Artificial Intelligence In Oncology Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on artificial intelligence in oncology market size, artificial intelligence in oncology market drivers and trends, artificial intelligence in oncology market major players, competitors' revenues, market positioning, and market growth across geographies. The artificial intelligence in oncology market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential. Browse Through More Similar Reports By The Business Research Company:
Artificial Intelligence In E-Commerce Global Market Report 2024

Global Artificial Intelligence in Oncology Market Poised for Growth, Expected to Reach $5.63 Billion by 2028

| Covers Valuable Guidance for Future AI Expansion Industry Players | CAGR 49.6%
The Artificial Intelligence (AI) in Medicine market is a rapidly growing segment of the healthcare industry that is expected to significantly transform the way healthcare is delivered in the future. AI technology has the potential to revolutionize healthcare by improving the accuracy, efficiency, and speed of medical diagnosis and treatment, while reducing costs. Artificial intelligence in medicine market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 to 2025. Some of the key players involved in the Market are:
InSilico Medicine, Inc., Globavir Biosciences, Inc., GNS Healthcare, Flatiron Health, Benevolent AI, Atomwise, Verge Genomics, Cloud Pharmaceuticals, and Recursion Pharmaceuticals. Download the Exclusive Sample Report (Including Graphs, Charts & Table & Figures) @ https://www.alliedmarketresearch.com/request-sample/4749
The Artificial Intelligence (AI) in Medicine market can be segmented based on various factors, including:
Technology: This segment includes machine learning, natural language processing, and others. Application: This segment includes imaging and diagnostics, drug discovery, virtual assistants, and others. End-user: This segment includes hospitals and clinics, pharmaceutical companies, research institutions, and others. Region: This segment includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these segments has its own unique characteristics and growth drivers. For example, the imaging and diagnostics segment is expected to witness significant growth due to the increasing demand for AI-based solutions in medical imaging, which can help to improve the accuracy and speed of diagnoses. Similarly, the hospital and clinics segment is expected to grow due to the increasing adoption of AI-based solutions in healthcare management and patient care. Understanding these segments is important for companies operating in the AI in medicine market, as it can help them to identify new opportunities and develop targeted strategies to address the specific needs of different customers and regions. Have Any Query? Ask Our Expert @: https://www.alliedmarketresearch.com/purchase-enquiry/4749
Our Market Research Solution Provides You Answer Below Mentioned Question:
• Which are the driving factors responsible for the growth of market? • Which are the roadblock factors of this market? • What are the new opportunities, by which market will grow in coming years? • What are the trends of this market? • Which are main factors responsible for new product launch? • How big is the global & regional market in terms of revenue, sales and production? • How far will the market grow in forecast period in terms of revenue, sales and production? • Which region is dominating the global market and what are the market shares of each region in the overall market in 2023? • How will each segment grow over the forecast period and how much revenue will these segments account for in 2030? • Which region has more opportunities? Read More Trending Reports Here:
Hereceptin Biosimilars Market https://www.alliedmarketresearch.com/hereceptin-biosimilars-market
AIAbout Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact:

Artificial Intelligence in Medicine Market 2025 | Covers Valuable Guidance for Future AI Expansion Industry Players | CAGR 49.6%

in Drug Discovery Market to Exhibit at a 49.6% CAGR during the Forecast Period 2020-2027
A new research report namely,  Artificial Intelligence (A.I.) in Drug Discovery Market by Type (Service, Software, Hardware), Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), Application (Personalized Medicine, Clinical Research Trial, Metabolic Diseases, Cardiovascular Diseases, Neurodegenerative Diseases, Immuno-oncology, Drug Discovery & Repurposing), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027 offers detailed and comparative analysis covering every aspect of the market. The report offers the past statistics of the market and the present state of the market with actual market numbers to support this data provided. The report includes data on numerous factors influencing the growth of the global Artificial Intelligence (A.I.) in Drug Discovery industry. The market report analyses all the industry dynamics thoroughly. It also includes the prediction for future market state or scope. It contains a comprehensive competitive landscape analysis, growth trends, and key regions’ expansion status. The global artificial intelligence (A.I.) in drug discovery market is expected to grow from USD 1.60 billion in 2019 to USD 40.36 billion by 2027, at a CAGR of 49.6% during the forecast period 2020-2027. DOWNLOAD FREE SAMPLE REPORT:  https://www.fiormarkets.com/report-detail/418371/request-sample  
Then, it specifies information about the key consolidations, acquisitions, and associations that are occurring in the business vertical. The report on the global Artificial Intelligence (A.I.) in Drug Discovery market further spotlights understanding the issues looked at by the arising business players and thus offers information in regards to the significant patterns and difficulties that may happen in the business space. The study provides marketplace members with critical figures as well as information on main customer preferences and prospects. Moreover, the report comprises important data about the contact information, production, company profiles, capacity, market revenue, market picture, product specification, and many others. Top key players profiled in this report are:
Intel Corporation, Google Inc., Microsoft Corporation, Enlitic, Inc., Berg Health, Welltok, Inc., IBM Corporation, BioXcel Corporation, Nvidia Corporation, General Vision, Inc., Globavir Biosciences, Benevolent AI, Verge Genomics, Recursion Pharmaceuticals, GNS Healthcare, Cloud Pharmaceuticals, InSilico Medicine, Atomwise and Flatiron Health. On the basis of product type, the market primarily split into:
Service
Personalized Medicine
Request for Customization:  https://www.fiormarkets.com/enquiry/request-customization/418371  
The report specifies an assessment of the organization’s products alongside their utilization worth and volume. The report also contains a comprehensive competitive landscape analysis, growth trends, and key regions’ expansion status is precisely studied. The market study also includes the prediction for future market state or scope. Also, the study states cost, prices, demand, export, and import data, and grows margins, supply figures, and revenues. Also, it delivers a detailed analysis of the global Artificial Intelligence (A.I.) in Drug Discovery market. Price structures and manufacturing procedures are also presented in this report. The precisely assessed and broadly analysed market conclusion is delivered in the report. In terms of region, the global Artificial Intelligence (A.I.) in Drug Discovery market is classified into: North America, Europe, Asia Pacific, South America, and the Middle East and Africa. ACCESS FULL REPORT:  https://www.fiormarkets.com/report/artificial-intelligence-a-i-in-drug-discovery-market-by-418371.html  
The report extensively studied the market segmentation along with the broad research on the basis of market revenue, market share, and other substantial factors. The report also helps to know how different segments are accrediting to the progress of the market. The research report also provides complete data of the key trends of segments involved in the market. It can be valuable for market players to extensively focus on high-growth areas of the target market. It evaluates the emerging market size, performance, and scope of each segment of the global Artificial Intelligence (A.I.) in Drug Discovery market. Customization of the Report: This report can be customized to meet the client’s requirements. Please connect with our sales team ( sales@fiormarkets.com ), who will ensure that you get a report that suits your needs. Contact Us

Global Artificial Intelligence (A.I.) in Drug Discovery Market to Exhibit at a 49.6% CAGR during the Forecast Period 2020-2027

Search jobs
30-Oct-2020
C-C Chemokine Receptor Type 4 Market Development, Size, Revenue, Future Growth, Business Prospects And Forecast To 2030
Pune, Maharashtra, India, October 30 2020 (Wiredrelease) Prudour Pvt. Ltd –:Market.us newly added its expanding treasury with a new research study. The research report, entitled &&&& C-C Chemokine Receptor Type 4 Market ,&&&& mainly includes a detailed segmentation of this sector that is expected to generate massive returns by the end of the outlook period, showing a significant growth rate on an anniversary basis over the coming years. The market report enriches with an exhaustive overview of product specification, technology, product type, and production analysis considering influential factors such as revenue, costing, and gross margin. C-C Chemokine Receptor Type 4 Market report also provides a competitive analysis of the key players operating in this market, along with their company sketches, product offerings, recent advancements, and key market crafts. The strategies covered in this c-c chemokine receptor type 4 market research report mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Global C-C Chemokine Receptor Type 4 Market is growing at a healthy CAGR in the above-mentioned research forecast period. The rising prevalence of genetic disorders is the factor responsible for the growth of the c-c chemokine receptor type 4 market. To Understand How Covid-19 Impact Is Covered In This Report, Get Free Covid-19 Sample @ https://market.us/report/c-c-chemokine-receptor-type-4-market/request-sample/
The Global C-C Chemokine Receptor Type 4 Market 2020 analysis gives a basic sketch of the industry including descriptions, classifications, applications, and industry chain structure. The Global C-C Chemokine Receptor Type 4 Market Share analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development strategies and plans are discussed as well as producing processes and cost structures are also analyzed. This report also states import/export expenditure, supply and demand Figures, cost, price, revenue, and gross margins. For each manufacturer covered, this report analyzes their c-c chemokine receptor type 4 manufacturing sites, capacity, production, ex-factory price, revenue, and market share in the global market. The report covers the key players of the global c-c chemokine receptor type 4 industry including company profiles, product specifications, production capacity/sales, revenue, price, and gross margin & sales by product types. Competitive Landscape and Global C-C Chemokine Receptor Type 4 Market Share Analysis
Global c-c chemokine receptor type 4 market competitive landscape provides details by competitor. Features included are company overview, company financials, revenue formed, market potential, investment in research and development, new market leadership, global bearing, production sites and facilities, company toughness and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to c-c chemokine receptor type 4 market. The major players covered in the global c-c chemokine receptor type 4 market are
Affitech A/S, AstraZeneca Plc, ChemoCentryx Inc, Corion Biotech Srl, FLX Bio Inc, Globavir Biosciences Inc, Kyowa Hakko Kirin Co Ltd, Ono Pharmaceutical Co Ltd
Inquire/Speak To Expert for Further Detailed Information Regarding How C-C Chemokine Receptor Type 4 Market Growing by 2030: https://market.us/report/c-c-chemokine-receptor-type-4-market/#inquiry
Global C-C Chemokine Receptor Type 4 Market Scope and Market Size
Global c-c chemokine receptor type 4 market is segmented based on type, end-users
Based on type, the global c-c chemokine receptor type 4 market is segmented into CCX-6239, E-0001163, GBV-3019, K-777. On the basis of end-users, the global c-c chemokine receptor type 4 market is segmented into Immunology, Central Nervous System, Mycosis Fungoides. C-C Chemokine Receptor Type 4 Market By Geography
North America
Queries Resolved In This Report:
What Will The Market Growth Rate, Overview And Analysis By Type Of Global C-C Chemokine Receptor Type 4 In 2030? What Are The Key Factors Driving, Analysis By Applications And Countries Global C-C Chemokine Receptor Type 4? What Are Dynamics, This Overview Includes Analysis Of Scope And Price Analysis Of Top Vendors Profiles Of Global C-C Chemokine Receptor Type 4? Who Are Opportunities, Risk And Driving Force Of Global C-C Chemokine Receptor Type 4? Who Are The Opportunities And Threats Faced By The Vendors In Global C-C Chemokine Receptor Type 4? Business Overview By Type, Applications, Gross Margin And Market Share
What Are The Global C-C Chemokine Receptor Type 4 Opportunities, Market Risk, And Market Overview Of The Market? Customized Research Report Using Corporate Email Id @ https://market.us/purchase-report/?report_id=39434
Insights of the report
Market Penetration: Comprehensive information on the product portfolios of the top players in the c-c chemokine receptor type 4 market. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the c-c chemokine receptor type 4 market. Competitive Assessment: In-depth assessment of the market policies, geographic, and industry segments of the leading players in the market. Market Development: General information about developing markets. This report analyzes the market for several segments across geographies. All the Challenges and growth opportunities in the c-c chemokine receptor type 4 market along with the market drivers and restraints. There are 15 Chapters to display the Global C-C Chemokine Receptor Type 4 Market
Chapter 1: Definition, Specifications and Classification of c-c chemokine receptor type 4, Applications of c-c chemokine receptor type 4, Market Segment by Regions;
Chapter 2: Manufacturing Cost Structure, Raw Material, and Suppliers, Manufacturing Process, Industry Chain Structure;
Chapter 3: Technical Data and Manufacturing Plants Analysis of c-c chemokine receptor type 4, Capacity, and Commercial Production Date, Manufacturing Plants Distribution, R&D Status, and Technology Source, Raw Materials Sources Analysis;
Chapter 4: Overall Market Analysis, Capacity Analysis (Company Segment), Sales Outline (Company Segment), Sales Price Analysis (Company Segment);
Chapter 5 and 6: Regional Market Analysis that carries United States, China, Europe, Japan, Korea & Taiwan, c-c chemokine receptor type 4 Segment Market Analysis (by Type);
Chapter 7 and 8: The c-c chemokine receptor type 4 Segment Market Analysis (by Application) Major Manufacturers Analysis of c-c chemokine receptor type 4
Chapter 9: Market Trend Analysis, Regional Market Trend, Market Trend by Product Type Invasive c-c chemokine receptor type 4, Non-Invasive c-c chemokine receptor type 4, Market Trend by Application;
Chapter 10: Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis;
Chapter 11: The Consumers Analysis of Global c-c chemokine receptor type 4;
Chapter 12: c-c chemokine receptor type 4 Research Findings and Conclusion, Appendix, methodology and data source;
Chapter 13, 14, and 15: c-c chemokine receptor type 4 sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source. Get Full TOC, Tables, and Figures of Market Report: https://market.us/report/c-c-chemokine-receptor-type-4-market/#toc
About Us:
Market.US specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report providing firm. Market.US provides customization to suit any specific or unique requirement and tailor-makes reports as per request. We go beyond boundaries to take analytics, analysis, study, and outlook to newer heights and broader horizons. We offer tactical and strategic support, which enables our esteemed clients to make well-informed business decisions and chart out future plans and attain success every single time. Besides analysis and scenarios, we provide insights into global, regional, and country-level information and data, to ensure nothing remains hidden in any target market. Our team of tried and tested individuals continues to break barriers in the field of market research as we forge forward with a new and ever-expanding focus on emerging markets. Get in Touch with Us :
Mr. Benni Johnson

C-C Chemokine Receptor Type 4 Market Development, Size, Revenue, Future Growth, Business Prospects And Forecast To 2030

The report titled “C-X-C Chemokine Receptor Type 4 Market: Size, Trends and Forecasts (2020-2025)”, delivers an in depth analysis of the C-X-C Chemokine Receptor Type 4 market by value, by production capacity, by companies, by applications, by segments, by region, etc. The report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the C-X-C Chemokine Receptor Type 4 industry. Growth of the overall C-X-C Chemokine Receptor Type 4 market has also been forecasted for the period 2020-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Request For Exclusive Sample PDF along with few company profiles 
Impact of COVID-19:
C-X-C Chemokine Receptor Type 4 Market report analyses the impact of Coronavirus (COVID-19) on the C-X-C Chemokine Receptor Type 4 industry. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 180+ countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the C-X-C Chemokine Receptor Type 4 market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; emergency declared in many countries; massive slowing of the supply chain; stock market unpredictability; falling business assurance, growing panic among the population, and uncertainty about future. COVID-19 can affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets. Get Sample ToC to understand the CORONA Virus/COVID19 impact and be smart in redefining business strategies. The major players profiled in this report include AdAlta Pty Ltd., Ambrx, Inc., Anchor Therapeutics, Inc., Biokine Therapeutics Ltd., BioLineRx, Ltd., Bristol-Myers Squibb Company, Eli Lilly and Company, Globavir Biosciences, Inc., GlycoMimetics, Inc., NeED Pharma s.r.l., Pharis Biotec GmbH, Polyphor Ltd., Sanofi, TaiGen Biotechnology Co., Ltd., Upsher-Smith Laboratories, Inc., X4 Pharmaceuticals, Inc..
Market Segments and Sub-segments Covered in the Report are as per below:
Based on Product Type C-X-C Chemokine Receptor Type 4 market is segmented into AM-3114, BL-8040, GMI-1359, HPH-112, Others
Based on Application C-X-C Chemokine Receptor Type 4 market is segmented into Liver Cancer, Myocardial Infarction, Renal Cell Carcinoma, Stroke, Others
Regional Coverage of the C-X-C Chemokine Receptor Type 4 Market:
Europe
Industrial Analysis of C-X-C Chemokine Receptor Type 4 Market:
Key Questions answered in the Report:
What is the size of the overall C-X-C Chemokine Receptor Type 4 market and its segments? What are the key segments and sub-segments in the market? What are the key drivers, restraints, opportunities and challenges of the C-X-C Chemokine Receptor Type 4 market and how they are expected to impact the market? What are the attractive investment opportunities within the Market? What is the C-X-C Chemokine Receptor Type 4 market size at the regional and country-level? Who are the key market players and their key competitors? Market value- chain and key trends impacting every node with reference to companies
What are the strategies for growth adopted by the key players in C-X-C Chemokine Receptor Type 4 market? How does a particular company rank against its competitors with respect to revenue, profit comparison, operational efficiency, cost competitiveness and market capitalization? How financially strong are the key players in C-X-C Chemokine Receptor Type 4 market (revenue and profit margin, market capitalization, expenditure analysis, investment analysis)? What are the recent trends in C-X-C Chemokine Receptor Type 4 market? (M&A, partnerships, new product developments, expansions)
Get Chance of 20% Extra Discount, If your Company is Listed in Above Key Players List

Global C-X-C Chemokine Receptor Type 4 Market 2020 Recovering From Covid-19 Outbreak | Know About Brand Players: AdAlta Pty Ltd., Ambrx, Inc., Anchor Therapeutics, Inc., etc. | InForGrowth

Suyog Diagnostics offers diagnostic equipment and reagents within the healthcare sector. The company has diagnostic products, including technologies, instruments, and consumables for disease treatment and medical testing. Suyog Diagnostics serves sectors such as microbiology, blood banks, pathology, and hematology. It was founded in 1996 and is based in Mumbai, India.

Suyog Diagnostics

NEW YORK -- A kit for detection of dengue virus manufactured by California-based Globavir Biosciences has been approved by the ministry of health and welfare in India , and the company has partnered with Suyog Diagnostics to distribute the test there .

Globavir Biosciences, Suyog Diagnostics to Market Dengue Test in India

Bio-Rad provides products for the healthcare industry, specifically in the life science research and clinical diagnostics sectors. The company offers products that assist in scientific discovery and medical diagnostic processes. Bio-Rad serves the life science research community and clinical diagnostic laboratories. It was founded in 1952 and is based in Hercules, California.

Bio-Rad

Sorrento Therapeutics offers developing therapies for a range of medical conditions. It offers treatments including cancer therapies, autoimmune and inflammatory disease treatments, as well as solutions for viral and neurodegenerative diseases. It also develops pain management solutions and is involved in antiviral therapies and vaccines related to the COVID-19 pandemic. It was founded in 2009 and is based in San Diego, California.

Sorrento Therapeutics

Genentech

UBS Securities

NYU Langone Health

Artificial Intelligence (AI)

Unattributed

Globavir is a specialty biotechnology company with a unique approach to unlocking the potential of the 505(b)(2) regulatory path. Globavir leverages its highly predictive, machine learning GDDP platform, initially developed at Stanford University, to generate small molecule candidates in oncology and infectious diseases. The company is exploring multiple infectious diseases with its lead product, GBV006, entering into Phase1b/2a clinical trial in the first half of 2016. Globavir is also developing a pipeline in immuno-oncology, targeting checkpoint inhibitor pathways and has exclusive global licenses to develop and commercialize a blood based diagnostic test platform from Stanford University.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
10/6/2015	Unattributed	$0.15M	Sorrento Therapeutics, and Undisclosed Investors	$XXM	0 FY undefined	3
11/13/2014	Incubator/Accelerator		Subscribe to see more	$XXM	0 FY undefined	10

Date	10/6/2015	11/13/2014
Round	Unattributed	Incubator/Accelerator
Amount	$0.15M
Investors	Sorrento Therapeutics, and Undisclosed Investors	Subscribe to see more
Valuation	$XXM	$XXM
Revenue	0 FY undefined	0 FY undefined
Sources	3	10

First funding	Last Funding	Investor	Rounds	Board Seats	Type	Location
10/6/2015	10/6/2015	Sorrento Therapeutics	1 Unattributed		Corporation	California
00/00/0000	00/00/0000	StartX	Subscribe to see more		Incubator/Accelerator	California

First funding	10/6/2015	00/00/0000
Last Funding	10/6/2015	00/00/0000
Investor	Sorrento Therapeutics	StartX
Rounds	1 Unattributed	Subscribe to see more
Board Seats
Type	Corporation	Incubator/Accelerator
Location	California	California

How VCs Use CB Insights

Professional Services

Platform Overview

Globavir Biosciences

Total Raised

Investors Count

Funding, Valuation & Revenue

Globavir Biosciences Investors